| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |